Intravenous-to-oral switch in antimicrobial therapy: clinical pharmacology considerations and perspectives

scientific article

Intravenous-to-oral switch in antimicrobial therapy: clinical pharmacology considerations and perspectives is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2217/FMB-2017-0075
P8608Fatcat IDrelease_n73ieojqyrgblnattuj24mwdia
P698PubMed publication ID28685614

P2093author name stringNuggehally R Srinivas
P2860cites workPharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotypeQ33608028
Absorption and disposition kinetics of amoxicillin in normal human subjectsQ33723729
Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolidQ34658779
Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjectsQ36460752
Influence of Morbidly Obesity on the Clinical Pharmacokinetics of Various Anti-Infective Drugs: Reappraisal Using Recent Case Studies-Issues, Dosing Implications, and ConsiderationsQ38696348
Oral administration of antibiotics: a rational alternative to the parenteral routeQ41440909
Linezolid absolute bioavailability and the effect of food on oral bioavailabilityQ43824945
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazoleQ44273424
Stimulation of the i.v. to oral switch of bioavailable drugs by phone calls in a Belgian tertiary care hospitalQ44569116
Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interactionQ46607069
Effect of gastric bypass surgery on azithromycin oral bioavailability.Q51340454
P407language of work or nameEnglishQ1860
P1104number of pages5
P304page(s)847-851
P577publication date2017-07-07
P1433published inFuture MicrobiologyQ15759961
P1476titleIntravenous-to-oral switch in antimicrobial therapy: clinical pharmacology considerations and perspectives
P478volume12